+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Swedish Orphan Biovitrum AB - logo

Sobi is a leading integrated biopharmaceutical company that focuses on developing therapies and treatments for haemophilia, inflammation, genetic and metabolic diseases. Its operations are split into three core areas: Core Products, Partner Products and ReFacto Manufacturing. The organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe. However, Europe accounts for up to 54 per cent of its sales. Sobi is headquartered in Stockholm, Sweden.

Graft Versus Host Disease (GVHD) (Immunology) - Drugs In Development, 2021 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) (Immunology) - Drugs In Development, 2021

  • Report
  • July 2021
  • 842 Pages
From
Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • September 2021
  • 1013 Pages
From
Gouty Arthritis (Gout) - Pipeline Review, H2 2020 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 139 Pages
From
Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027 - Product Thumbnail Image

Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027

  • Report
  • April 2022
  • 326 Pages
From
Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • May 2018
  • 89 Pages
From
Idiopathic Thrombocytopenic Purpura (Hematology) - Drugs In Development, 2021 - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura (Hematology) - Drugs In Development, 2021

  • Report
  • July 2021
  • 205 Pages
From
Bone Marrow Transplant Rejection (Immunology) - Drugs In Development, 2021 - Product Thumbnail Image

Bone Marrow Transplant Rejection (Immunology) - Drugs In Development, 2021

  • Report
  • July 2021
  • 856 Pages
From
Ulcerative Colitis (Gastrointestinal) - Drugs In Development, 2021 - Product Thumbnail Image

Ulcerative Colitis (Gastrointestinal) - Drugs In Development, 2021

  • Report
  • July 2021
  • 941 Pages
From
Interleukin 1 (IL1) - Drugs in Development, 2021 - Product Thumbnail Image

Interleukin 1 (IL1) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

  • Report
  • April 2020
  • 536 Pages
From
Rheumatoid Arthritis Drugs Market by Drug Class, Route of Administration, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market by Drug Class, Route of Administration, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • Report
  • October 2020
  • 219 Pages
From
Middle East and Turkey Chronic Liver Disease Therapeutics Market, by Disease Type, by Drug Class, by Route of Administration, by Distribution Channel, and by Country - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 - Product Thumbnail Image

Middle East and Turkey Chronic Liver Disease Therapeutics Market, by Disease Type, by Drug Class, by Route of Administration, by Distribution Channel, and by Country - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • Report
  • February 2022
  • 211 Pages
From
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 160 Pages
From
Chemotherapy-induced Thrombocytopenia Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 - Product Thumbnail Image

Chemotherapy-induced Thrombocytopenia Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • Report
  • December 2020
From
Hemophilia Drugs - Global Market Trajectory & Analytics - Product Thumbnail Image

Hemophilia Drugs - Global Market Trajectory & Analytics

  • Report
  • April 2021
  • 180 Pages
From
Ulcerative Colitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 779 Pages
From
Hemophilia Treatment Market Research Report by Product Type, Disease Indication, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Hemophilia Treatment Market Research Report by Product Type, Disease Indication, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • April 2022
  • 208 Pages
From
Hemophilia Treatment Drugs Market Research Report by Product Type, Disease Indication, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Hemophilia Treatment Drugs Market Research Report by Product Type, Disease Indication, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • April 2022
  • 211 Pages
From
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021 - Product Thumbnail Image

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021

  • Report
  • November 2021
  • 115 Pages
From
Hemophilia Treatment Drugs Market Research Report by Product Type, Disease Indication, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Hemophilia Treatment Drugs Market Research Report by Product Type, Disease Indication, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • April 2022
  • 100 Pages
From
Loading Indicator